| Dr Denise Michelle Pisatowski, MD | |
|
4 Walter E Foran Blvd Ste 302, Flemington, NJ 08822-4668 | |
| (908) 806-0080 | |
| (908) 806-8570 |
| Full Name | Dr Denise Michelle Pisatowski |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 32 Years |
| Location | 4 Walter E Foran Blvd Ste 302, Flemington, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669468856 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 25MA05998700 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hunterdon Medical Center | Flemington, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Obstetric And Gyn Llc | 7315835824 | 9 |
News Archive
SEEK, a privately owned biopharmaceutical company specializing in immunology, announces today that it has completed a Phase Ib/II clinical trial of its HIV-v vaccine which demonstrates a one log (approx 90 percent) difference in viral count in HIV-infected people compared with the placebo group, after just a single vaccine injection.
Patients with advanced hepatocellular (or liver) cancer have high mortality rates, with existing drugs demonstrating only a small, but significant survival advantage. By combining a zebrafish model of liver cancer with data from human tumors, researchers from the Icahn School of Medicine at Mount Sinai hope to identify potential genes of interest that can be targeted for new treatments for hepatocellular carcinoma, the most common form of liver cancer to develop from liver cells.
A survey released today by the Center for Healthcare Research & Transformation challenges the long-held assumption that having health insurance is synonymous with having access to health care.
Fluidigm Corporation, the inventor of integrated fluidic circuits (IFCs), has appointed Nano Gen Teknolojileri Ltd. as its exclusive distributor for the BioMark™ and EP1™ Systems for genetic analysis in Turkey. The BioMark System provides significant advantages for digital and real-time PCR, genotyping, single-cell gene expression, cancer detection and absolute quantification.
The Administration announced on Tuesday, July 2, that it is postponing for one year the requirement that employers with 50 or more full-time employees provide health insurance to such employees or face significant monetary penalties.
› Verified 9 days ago
| Entity Name | Advanced Obstetric & Gyn Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205882602 PECOS PAC ID: 7315835824 Enrollment ID: O20040308000196 |
News Archive
SEEK, a privately owned biopharmaceutical company specializing in immunology, announces today that it has completed a Phase Ib/II clinical trial of its HIV-v vaccine which demonstrates a one log (approx 90 percent) difference in viral count in HIV-infected people compared with the placebo group, after just a single vaccine injection.
Patients with advanced hepatocellular (or liver) cancer have high mortality rates, with existing drugs demonstrating only a small, but significant survival advantage. By combining a zebrafish model of liver cancer with data from human tumors, researchers from the Icahn School of Medicine at Mount Sinai hope to identify potential genes of interest that can be targeted for new treatments for hepatocellular carcinoma, the most common form of liver cancer to develop from liver cells.
A survey released today by the Center for Healthcare Research & Transformation challenges the long-held assumption that having health insurance is synonymous with having access to health care.
Fluidigm Corporation, the inventor of integrated fluidic circuits (IFCs), has appointed Nano Gen Teknolojileri Ltd. as its exclusive distributor for the BioMark™ and EP1™ Systems for genetic analysis in Turkey. The BioMark System provides significant advantages for digital and real-time PCR, genotyping, single-cell gene expression, cancer detection and absolute quantification.
The Administration announced on Tuesday, July 2, that it is postponing for one year the requirement that employers with 50 or more full-time employees provide health insurance to such employees or face significant monetary penalties.
› Verified 9 days ago
| Entity Name | Affiliates In Ob Gyn Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568561637 PECOS PAC ID: 3476548108 Enrollment ID: O20040420000730 |
News Archive
SEEK, a privately owned biopharmaceutical company specializing in immunology, announces today that it has completed a Phase Ib/II clinical trial of its HIV-v vaccine which demonstrates a one log (approx 90 percent) difference in viral count in HIV-infected people compared with the placebo group, after just a single vaccine injection.
Patients with advanced hepatocellular (or liver) cancer have high mortality rates, with existing drugs demonstrating only a small, but significant survival advantage. By combining a zebrafish model of liver cancer with data from human tumors, researchers from the Icahn School of Medicine at Mount Sinai hope to identify potential genes of interest that can be targeted for new treatments for hepatocellular carcinoma, the most common form of liver cancer to develop from liver cells.
A survey released today by the Center for Healthcare Research & Transformation challenges the long-held assumption that having health insurance is synonymous with having access to health care.
Fluidigm Corporation, the inventor of integrated fluidic circuits (IFCs), has appointed Nano Gen Teknolojileri Ltd. as its exclusive distributor for the BioMark™ and EP1™ Systems for genetic analysis in Turkey. The BioMark System provides significant advantages for digital and real-time PCR, genotyping, single-cell gene expression, cancer detection and absolute quantification.
The Administration announced on Tuesday, July 2, that it is postponing for one year the requirement that employers with 50 or more full-time employees provide health insurance to such employees or face significant monetary penalties.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Denise Michelle Pisatowski, MD 4 Walter E Foran Blvd Ste 302, Flemington, NJ 08822-4668 Ph: (908) 284-5295 | Dr Denise Michelle Pisatowski, MD 4 Walter E Foran Blvd Ste 302, Flemington, NJ 08822-4668 Ph: (908) 806-0080 |
News Archive
SEEK, a privately owned biopharmaceutical company specializing in immunology, announces today that it has completed a Phase Ib/II clinical trial of its HIV-v vaccine which demonstrates a one log (approx 90 percent) difference in viral count in HIV-infected people compared with the placebo group, after just a single vaccine injection.
Patients with advanced hepatocellular (or liver) cancer have high mortality rates, with existing drugs demonstrating only a small, but significant survival advantage. By combining a zebrafish model of liver cancer with data from human tumors, researchers from the Icahn School of Medicine at Mount Sinai hope to identify potential genes of interest that can be targeted for new treatments for hepatocellular carcinoma, the most common form of liver cancer to develop from liver cells.
A survey released today by the Center for Healthcare Research & Transformation challenges the long-held assumption that having health insurance is synonymous with having access to health care.
Fluidigm Corporation, the inventor of integrated fluidic circuits (IFCs), has appointed Nano Gen Teknolojileri Ltd. as its exclusive distributor for the BioMark™ and EP1™ Systems for genetic analysis in Turkey. The BioMark System provides significant advantages for digital and real-time PCR, genotyping, single-cell gene expression, cancer detection and absolute quantification.
The Administration announced on Tuesday, July 2, that it is postponing for one year the requirement that employers with 50 or more full-time employees provide health insurance to such employees or face significant monetary penalties.
› Verified 9 days ago
Ruby P. Huttner, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 111 State Route 31, Suite 121, Flemington, NJ 08822 Phone: 908-782-2825 Fax: 908-782-0196 | |
Dr. Mamie Sue Bowers, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1100 Wescott Dr, Suite 105, Flemington, NJ 08822 Phone: 908-788-6469 Fax: 908-788-6483 | |
Dr. Melissa Rae Camiolo, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4 Walter E Foran Blvd Ste 302, Flemington, NJ 08822 Phone: 908-806-0080 Fax: 908-806-8570 | |
Dr. Deirdre C Masterton, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4 Walter E Foran Blvd, Suite 302, Flemington, NJ 08822 Phone: 908-284-5295 Fax: 908-806-8570 | |
Dr. Manisha G Abeysinghe, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4 Walter E Foran Blvd, Ste 302, Flemington, NJ 08822 Phone: 908-806-0080 Fax: 908-806-8570 | |
Dr. Yelena Belkina, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4 Walter E Foran Blvd Ste 302, Flemington, NJ 08822 Phone: 908-806-0080 | |
Dr. Jimena Rivas, M.D Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4 Walter E Foran Blvd Ste 302, Flemington, NJ 08822 Phone: 908-806-0080 |